4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Revenue

4D Molecular Therapeutics had revenue of $3.78M in the quarter ending June 30, 2026, with 25,106.67% growth. This brings the company's total for the last twelve months to $92.01M, up 278,712.12% year-over-year. In the year 2025, 4D Molecular Therapeutics had annual revenue of $85.21M with 230,194.59% growth. That makes 4D Molecular Therapeutics the 23,279th largest company in the world by revenue and 3,347th in the United States.

• Revenue (ttm): $92.01M
• Revenue Growth: +278,712.12%
• P/S Ratio: 7.43
• Revenue / Employee: $469,429
• Employees: 196
• Market Cap: 679.23M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Japan 85.00M 99.8%
• United States 209.00K 0.2%

Fiscal year ended Dec 31, 2025 See the full 4D Molecular Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	85.21M	85.17M	230,194.59%
Dec 31, 2024	37.00K	-20.69M	-99.82%
Dec 31, 2023	20.72M	17.59M	562.29%
Dec 31, 2022	3.13M	-14.91M	-82.65%
Dec 31, 2021	18.04M	4.43M	32.52%
Dec 31, 2020	13.61M	6.63M	94.85%
Dec 31, 2019	6.99M	-7.14M	-50.56%
Dec 31, 2018	14.13M	8.34M	144.04%
Dec 31, 2017	5.79M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error